Precision BioSciences, Inc. (DTIL) vs Whitehawk Therapeutics, Inc. (WHWK)

Precision BioSciences, Inc. and Whitehawk Therapeutics, Inc. are both Biotechnology companies. Precision BioSciences, Inc. and Whitehawk Therapeutics, Inc. are of similar size ($173.3M and $170.3M). Whitehawk Therapeutics, Inc. grew revenue faster over the last twelve months: 16.5% against −11.9%. Across the 14 metrics below, Whitehawk Therapeutics, Inc. leads on 11 and Precision BioSciences, Inc. on 3.

Valuation

Metric DTIL WHWK Biotechnology median
P/E n/m n/m 8.50
P/S 3.31 8.65 9.71
P/B 3.29 1.31 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 1.87 1.85 9.21
Earnings yield (48.35%) (38.62%) (33.15%)
Free cash flow yield (35.07%) (29.08%) (25.50%)

Profitability

Metric DTIL WHWK Biotechnology median
Gross margin 100.00% 88.72% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (132.91%) (44.98%) (56.36%)
Return on assets (44.91%) (42.60%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric DTIL WHWK Biotechnology median
Revenue growth (TTM) (11.87%) 16.51% 6.02%
EPS growth (last fiscal year) (442.31%) 86.02% 30.26%
Revenue growth, 5-year CAGR 7.13% (13.29%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DTIL WHWK Biotechnology median
Debt to equity 0.50 0.00 0.00
Current ratio 12.82 17.38 4.72
Net debt to EBITDA 1.86 1.26 0.96

Dividend

Metric DTIL WHWK Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DTIL WHWK Biotechnology median
Market cap 170.30m 173.31m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack